Clinical Trials Browser

Phase 2 × daratumumab × Thoracic × Clear all

NCT05807048 2026-03-10

Daratumumab in STK11 Mutated NSCLC

Phase 2 Completed

Non-small Cell Lung Cancer With STK11/LKB1 Mutation

NCT06015724 2025-07-28

DARANIVOVAX

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung